Evidence map›Paper›PMID 42038625›Full record

ArticleAntimicrobial stewardship & healthcare epidemiology : ASHE2026

The changing epidemiology and long-term outcomes of patients with CRE infections.

Sunish Shah, Lloyd G Clarke, Erin K McCreary, Ellen G Kline, Emre Yucel, Alexandre H Watanabe, Ryan K Shields

Abstract read
In one paragraph

Article in Antimicrobial stewardship & healthcare epidemiology : ASHE, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Differential virulence potential of different clades of multidrug-resistantmedRxiv : the preprint server for health sciences · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sunish ShahDepartment of Pharmacy, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.ORCID https://orcid.org/0000-0002-8873-1451
Lloyd G ClarkeDepartment of Pharmacy, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Erin K McCrearyDepartment of Pharmacy, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.ORCID https://orcid.org/0000-0001-6705-2225
Ellen G KlineDivision of Infectious Diseases, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.ORCID https://orcid.org/0009-0006-7167-6368
Emre YucelMerck: Merck & Co Inc, USA.ORCID https://orcid.org/0000-0002-6036-9526
Alexandre H WatanabeMerck: Merck & Co Inc, USA.
Ryan K ShieldsDivision of Infectious Diseases, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.ORCID https://orcid.org/0000-0001-9794-5665

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The impact of organism species and underlying comorbidities on long-term clinical outcomes for patients with carbapenem-resistant Enterobacterales (CRE) infections is unknown. Methods: Patients with CRE-positive cultures from 2011 to 2019 were monitored for 1-year. Patients without signs of infection were categorized as colonization. Recurrent cases were defined as isolation of the same CRE species >90 days after the index case. Results: 720 patients met inclusion criteria and accounted for 749 index cases, which decreased over time. The median (range) age was 61 (20-97) years, 53% (397/749) were male, 20% (151/749) received solid organ transplant (SOT), and 44% resided in the ICU at the time of CRE isolation. The colonization rate was 34% (257/749). Pneumonia and bacteremia represented the most common infection types accounting for 25% (185/749) and 13% (95/749) of all cases, respectively. Conclusion: CRE are increasingly diverse and associated with significant morbidity and healthcare utilization across varying patient groups. Long-term survival of patients infected with CRE has improved over time while overall incidence of CRE has decreased.

Identifiers

PMID42038625
PMCPMC13104517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.